Insulin reduces obesity-related inflammation
By ANITuesday, May 11, 2010
WASHINGTON - Scientists have found that one of the most common side effects of obesity - inflammation - can be fought by administering insulin.
As an added benefit, the team behind the work says, this also reduces a person’s risk of developing diabetes.
The remarkable finding was recently presented in a new thesis, written by experts at the Sahlgrenska Academy of the University of Gothenburg, in Sweden.
When you put on weight, your fat tissue grows and begins to produce a wealth of inflammatory molecules.
The increase in these inflammatory molecules leaves the fat tissue in a state of chronic inflammation.
This plays an important role in the development of insulin resistance, an early stage of type 2 diabetes, where the body is unable to regulate blood sugar levels using its own insulin.
“It’s still not entirely clear why obesity causes insulin resistance. Inflammation could be part of the reason why obesity leads to type 2 diabetes,” said Emelie Wallerstedt from the Institute of Medicine at the University of Gothenburg.
Research has shown that both obesity and insulin resistance are affected by inflammatory conditions in the body.
Previously it was believed that fat tissue served merely as a depository for fat, but now scientists know that it is also an important organ for the release of a wide range of different substances, including inflammatory molecules.
In the new study, the researchers managed to identify the properties of the inflammatory molecule IL-6.
“IL-6 impairs insulin signalling, but the insulin signalling itself can also inhibit and ‘turn off’ the IL-6 signal and inflammation. The protein PKCdelta also plays an important role in the regulation of the IL-6 signal, and we have shown that if we disable the function of this molecule, the inflammation decreases,” Wallerstedt said.
A greater understanding of these signalling mechanisms could make it possible in the future to develop medicines that can “turn off” the inflammation and so reduce the risk of insulin resistance and other obesity-related disorders. (ANI)
